He discusses his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell...
He discusses his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell...
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
Jane Yee, MD, answers our questions about the prevention of COVID-19 among patients with HIV, the risks these patients may face if they are exposed to the novel coronavirus, and the importance of ensuring...
Jane Yee, MD, answers our questions about the prevention of COVID-19 among patients with HIV, the risks these patients may face if they are exposed to the novel coronavirus, and the importance of ensuring...
In this podcast, Bill Kapogiannis, MD, discusses the multi-Federal agency SMILE Collaborative (Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of HIV-infected youth),...
Researchers from the CDC’s Office of Antibiotic Stewardship have determined that outpatient antibiotic prescription rates in the United States have decreased in recent years. In this Q&A, the Office...
In this podcast, Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of US surveillance data of adults with HIV infection that examined the...
Lorenzo Subissi, PhD, answers our questions about his study that investigated subsequent mortality among people discharged from a treatment center after the 2013-2016 Ebola outbreak in West Africa.
